The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.
about
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study.Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions.Dose intensity analysis in advanced ovarian cancer patients.High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy.Does intensified chemotherapy increase survival outcomes of osteosarcoma patients? A meta-analysis.
P2860
Q33373879-90853BC9-DFD3-4A5D-9100-40E088E2BB38Q33404434-D999B5DD-8D74-4B6E-B339-2AA916356AD6Q33436456-15362407-02C2-43C5-85DE-138454E51506Q35975958-EBF63E5E-B1F9-469A-BD82-B91A9BDED646Q36114975-99E53F1C-A20C-4972-A508-AA1EAFF854C2Q43583142-EC8CB44E-5A65-439D-A66E-AD9FAE4BD9A1Q44086089-C533E893-AF77-446F-AE5A-F55BA07B7A99Q44103047-C4F532F0-E4D8-4118-BAA6-6A7D2F1C6EA0Q48179867-AF2A1F1A-E0E9-48AE-9C4F-B6088587E9C8Q55439578-DEA73182-30EE-4F1E-98B2-FA6CD241A988
P2860
The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@en
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@nl
type
label
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@en
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@nl
prefLabel
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@en
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@nl
P2093
P356
P1476
The role of dose intensity in ...... -grade non-Hodgkin's lymphoma.
@en
P2093
M D Goodyear
W M Hryniuk
P304
P356
10.1200/JCO.1991.9.2.339
P407
P577
1991-02-01T00:00:00Z